Related Experiment Video
Updated: Nov 13, 2025
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer
Kimishige Akino1, Minoru Toyota, Hiromu Suzuki
1First Department of Internal Medicine, Cancer Research Institute, Sapporo Medical University, Japan.
Background & Aims:
Activation of Ras signaling is a hallmark of colorectal cancer (CRC), but the roles of negative regulators of Ras are not fully understood. Our aim was to address that question by surveying genetic and epigenetic alterations of Ras-Ras effector genes in CRC cells.
Methods:
The expression and methylation status of 6 RASSF family genes were examined using RT-PCR and bisulfite PCR in CRC cell lines and in primary CRCs and colorectal adenomas. Colony formation assays and flow cytometry were used to assess the tumor suppressor activities of RASSF1 and RASSF2. Immunofluorescence microscopy was used to determine the effect of altered RASSF2 expression on cell morphology. Mutations of K- ras , BRAF, and p53 were identified using single-strand conformation analysis and direct sequencing.
Results:
Aberrant methylation and histone deacetylation of RASSF2 was associated with the gene's silencing in CRC. The activities of RASSF2, which were distinct from those of RASSF1, included induction of morphologic changes and apoptosis; moreover, its ability to prevent cell transformation suggests that RASSF2 acts as a tumor suppressor in CRC. Primary CRCs that showed K- ras /BRAF mutations also frequently showed RASSF2 methylation, and inactivation of RASSF2 enhanced K- ras -induced oncogenic transformation. RASSF2 methylation was also frequently identified in colorectal adenomas.
Conclusions:
RASSF2 is a novel tumor suppressor gene that regulates Ras signaling and plays a pivotal role in the early stages of colorectal tumorigenesis.
Insights
Ras pathway activation drives colorectal cancer (CRC). Researchers found RASSF2 methylation silences this tumor suppressor gene, promoting CRC development and K-ras-induced transformation.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Ras signaling pathway activation is a key event in colorectal cancer (CRC) development.
- The function of negative regulators within the Ras pathway, particularly in CRC, remains incompletely understood.
- This study investigates genetic and epigenetic alterations in Ras-Ras effector genes in CRC.
Purpose of the Study:
- To survey genetic and epigenetic alterations of Ras-Ras effector genes in colorectal cancer (CRC) cells.
- To elucidate the role of RASSF family genes as negative regulators of Ras signaling in CRC.
- To assess the tumor suppressor activities of RASSF1 and RASSF2 in CRC.
Main Methods:
- Examined expression and methylation of 6 RASSF family genes in CRC cell lines, primary CRCs, and adenomas using RT-PCR and bisulfite PCR.
- Assessed tumor suppressor activities of RASSF1 and RASSF2 via colony formation assays and flow cytometry.
- Identified mutations in K-ras, BRAF, and p53 using single-strand conformation analysis and direct sequencing.
Main Results:
- RASSF2 silencing in CRC is linked to aberrant methylation and histone deacetylation.
- RASSF2 exhibits tumor suppressor functions, including inducing apoptosis and morphologic changes, distinct from RASSF1.
- RASSF2 methylation frequently occurred with K-ras/BRAF mutations in CRCs and adenomas, enhancing K-ras-induced transformation.
Conclusions:
- RASSF2 functions as a novel tumor suppressor gene in colorectal cancer.
- RASSF2 plays a critical role in regulating Ras signaling.
- RASSF2 inactivation is implicated in the early stages of colorectal tumorigenesis.
Related Concept Videos
02:38The Ras Gene
Ras is a...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:23Abnormal Proliferation
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...